We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+9.39%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$2.79B
AUM Growth
+$43.5M
Cap. Flow
-$119M
Cap. Flow %
-4.26%
Top 10 Hldgs %
21.05%
Holding
320
New
22
Increased
57
Reduced
195
Closed
20

Sector Composition

Rank Sector Weight
1 Healthcare 22.1%
2 Industrials 19.79%
3 Technology 17.45%
4 Consumer Discretionary 9.85%
5 Communication Services 8.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AIN icon
51
Albany International
AIN
$1.78B
$19.2M 0.69%
241,094
-69,792
-22% -$5.05M
PRTY
52
DELISTED
Party City Holdco Inc.
PRTY
$19M 0.68%
1,402,698
+202,877
+17% +$3.11M
OMCL icon
53
Omnicell
OMCL
$1.68B
$18.9M 0.68%
263,246
-98,482
-27% -$6.2M
CMCO icon
54
Columbus McKinnon
CMCO
$584M
$18.8M 0.67%
475,799
+16,268
+4% +$680K
ENSG icon
55
The Ensign Group
ENSG
$10.7B
$18.8M 0.67%
529,373
+113,702
+27% +$3.96M
OIS icon
56
Oil States International
OIS
$491M
$18.8M 0.67%
565,438
-5,615
-1% -$183K
DNOW icon
57
DNOW Inc
DNOW
$2.99B
$18.7M 0.67%
1,130,050
-15,720
-1% -$249K
MDSO
58
DELISTED
Medidata Solutions, Inc.
MDSO
$18.5M 0.66%
251,973
+130,070
+107% +$10.4M
TILE icon
59
Interface
TILE
$2.22B
$18.3M 0.66%
785,669
-9,021
-1% -$209K
CRS icon
60
Carpenter Technology
CRS
$28.4B
$17.6M 0.63%
299,062
-3,421
-1% -$196K
ACHC icon
61
Acadia Healthcare
ACHC
$2.94B
$17.3M 0.62%
491,992
-10,696
-2% -$426K
AERI
62
DELISTED
Aerie Pharmaceuticals
AERI
$17.1M 0.61%
278,073
-6,689
-2% -$430K
HAIN icon
63
Hain Celestial
HAIN
$53.7M
$17.1M 0.61%
628,748
-20,390
-3% -$582K
OXM icon
64
Oxford Industries
OXM
$552M
$16.8M 0.6%
186,794
-5,079
-3% -$462K
MEI icon
65
Methode Electronics
MEI
$592M
$16.7M 0.6%
460,166
-5,220
-1% -$204K
APOG icon
66
Apogee Enterprises
APOG
$908M
$16.4M 0.59%
396,278
-4,300
-1% -$208K
CVGW
67
DELISTED
Calavo Growers
CVGW
$16.3M 0.59%
169,196
+78,197
+86% +$7.72M
GMED icon
68
Globus Medical
GMED
$11.2B
$16.2M 0.58%
286,095
-3,164
-1% -$167K
COHR icon
69
Coherent
COHR
$74.2B
$16.2M 0.58%
342,335
+118,967
+53% +$5.41M
PCRX icon
70
Pacira BioSciences
PCRX
$997M
$16.2M 0.58%
329,258
-8,774
-3% -$379K
ACIW icon
71
ACI Worldwide
ACIW
$5.42B
$16.1M 0.58%
573,287
-12,287
-2% -$335K
RAMP icon
72
LiveRamp
RAMP
$2.3B
$15.8M 0.57%
320,134
-191,084
-37% -$8.46M
DPLO
73
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
$15.7M 0.56%
809,257
-9,682
-1% -$206K
NGVT icon
74
Ingevity
NGVT
$2.68B
$15.6M 0.56%
153,095
+30,147
+25% +$2.91M
BANR icon
75
Banner Corp
BANR
$2.4B
$15.4M 0.55%
247,516
-3,278
-1% -$209K

Similar funds

Rice Hall James & Associates's Q3 2018 Portfolio in Review

As of Q3 2018, Rice Hall James & Associates held 320 positions worth $2.79B, up 1.6% from $2.75B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Rice Hall James & Associates withdrew a net $119M in Q3 2018, closing 20 positions and reducing 195 holdings. Its most notable exit was AMN Healthcare, an estimated $19.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Industrials and Technology.

Against the trend, Rice Hall James & Associates opened a new position in The Aaron's Company Inc Class A worth $23.7M.

  • Rice Hall James & Associates's largest Q3 2018 buy was The Aaron's Company Inc Class A: 434,872 shares worth $23.7M.
  • Rice Hall James & Associates added most to Children's Place in Q3 2018, an estimated $10.9M increase.
  • Rice Hall James & Associates's biggest Q3 2018 reduction was Tetra Tech, cutting an estimated $25.2M.
  • Rice Hall James & Associates fully exited AMN Healthcare in Q3 2018, selling an estimated $19.6M.
  • Rice Hall James & Associates's ten largest holdings make up 21% of its $2.79B portfolio in Q3 2018.
  • Rice Hall James & Associates opened 22 new positions and closed 20 in Q3 2018.
  • Rice Hall James & Associates's portfolio value rose 1.6% quarter-over-quarter to $2.79B.

Based on Rice Hall James & Associates's 13F filing for Q3 2018, filed 25 Oct 2018.